Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACXP is expected to report earnings to rise 137.50% to -37 cents per share on May 08

Acurx Pharmaceuticals ACXP Stock Earnings Reports

Q1'25

Est.

$-0.38

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.02

Q2'24

Missed

by $0.09

Q1'24

Missed

by $0.04

The last earnings report on March 18 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 194.10K shares outstanding, the current market capitalization sits at 7.91M.

View a ticker or compare two or three

Compare

ACXP